
HealthTech companies are pushing boundaries every day - developing technologies that diagnose faster, treat more effectively, and improve patient outcomes. But with rapid progress comes exposure. In this space, ideas can be copied, partnerships can become complicated, and public trust can be fragile. Protecting your intellectual property isn’t a luxury - it’s essential for survival and growth.
HealthTech occupies a unique position at the intersection of healthcare, data science, and technology. It’s an exhilarating space, but it also carries significant risks. From AI-powered diagnostic tools and telemedicine platforms to wearable health trackers and biotech solutions, companies are under constant pressure to innovate quickly while ensuring their protection. The headlines are filled with cautionary tales: innovative start-ups caught off guard by IP disputes, data privacy scandals undermining trust, and well-capitalised competitors rapidly replicating successful concepts. If you’re developing something valuable, the question isn’t whether you’ll encounter these challenges - it’s when.
Patent wars aren’t just for big pharma anymore. HealthTech start-ups developing novel algorithms or wearable sensors often find themselves facing patent infringement claims from large incumbents. In 2023, a well-known wearable device maker sued a promising start-up over heart rate analysis technology. The start-up’s funding round collapsed under legal pressure.
It’s not always aggressive enforcement - sometimes, it’s genuine overlap in crowded areas like remote monitoring or diagnostic platforms. Founders need:
HealthTech innovation runs on data, but managing it is fraught with complexity. Data ownership disputes are becoming common. For example, a leading fertility app faced backlash after repurposing aggregated user data for research without explicit consent. A regulatory investigation followed.
Beyond consent issues, there’s the challenge of third-party datasets. A biotech company recently had to pull its product after relying on clinical datasets that didn’t carry commercial usage rights. The damage wasn’t just legal - investor confidence took a hit.
Many HealthTech companies partner with academic researchers, hospitals, or external developers. But poorly drafted agreements can be costly. A diagnostic start-up found itself locked in arbitration after its university partner claimed co-ownership of its core software IP. The dispute lasted 18 months, stalling product rollout and shaking investor trust.
If your platform is successful, someone will copy it. The CEO of a UK telemedicine start-up publicly recounted how a competitor in Eastern Europe launched an identical platform - the same colour scheme, similar name, and mirrored user journey. Fighting international IP battles is expensive and draining.
AI-based health tools are surging. But IP law around AI-generated outputs is still evolving. Start-ups developing AI diagnostics are grappling with questions like:
The lack of clear rules makes proactive legal strategy essential.
Aggressive enforcement can backfire in healthcare. During the COVID-19 pandemic, a large med-tech company sued a volunteer group building low-cost ventilators, sparking global outrage. Reputation matters - especially in health.
These are all areas we can assist, contact us today and find out how.
You’re innovating for the future of healthcare. But that future needs protection. Decisis Law helps HealthTech businesses secure their intellectual property, avoid common pitfalls, and maintain public trust - giving you the confidence to innovate, scale, and lead.